| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2023 ( Subtotal = -$160,284 ) |
| | 2023 | 2022 | ELORAC INC | 100 N FAIRWAY DR | VERNON HILLS | IL | 60061-1859 | LAKE | USA | R43EY033606 | Civamide Nasal Spray for the Treatment of Dry Eye | 000 | 1 | NIH | 10/28/2022 | $0 |
| | 2023 | 2022 | ELORAC INC | 100 N FAIRWAY DR | VERNON HILLS | IL | 60061-1859 | LAKE | USA | R01FD005396 | Naloxone Lotion for the Treatment of Pruritus in Mycosis Fungoides | 001 | 4 | FDA | 12/12/2022 | $0 |
| | 2023 | 2022 | ELORAC INC | 100 N FAIRWAY DR | VERNON HILLS | IL | 60061-1859 | LAKE | USA | R01FD005396 | Naloxone Lotion for the Treatment of Pruritus in Mycosis Fungoides | 000 | 4 | FDA | 11/10/2022 | $0 |
| | 2023 | 2022 | ELORAC INC | 100 N FAIRWAY DR | VERNON HILLS | IL | 60061-1859 | LAKE | USA | R43EY033606 | Civamide Nasal Spray for the Treatment of Dry Eye | 001 | 1 | NIH | 7/28/2023 | -$160,284 |
|
| Issue Date FY: 2022 ( Subtotal = $240,284 ) |
| | 2022 | 2022 | ELORAC INC | 100 N FAIRWAY DR | VERNON HILLS | IL | 60061-1859 | LAKE | USA | R01FD005396 | Naloxone Lotion for the Treatment of Pruritus in Mycosis Fungoides | 000 | 4 | FDA | 8/29/2022 | $80,000 |
| | 2022 | 2022 | ELORAC, INC. | 100 FAIRWAY DR STE 134 | VERNON HILLS | IL | 60061-1859 | LAKE | USA | R43EY033606 | Civamide Nasal Spray for the Treatment of Dry Eye | 000 | 1 | NIH | 1/28/2022 | $160,284 |
|
| Issue Date FY: 2021 ( Subtotal = $298,000 ) |
| | 2021 | 2021 | ELORAC, INC. | 100 FAIRWAY DR STE 134 | VERNON HILLS | IL | 60061-1859 | LAKE | USA | R01FD005396 | Naloxone Lotion for the Treatment of Pruritus in Mycosis Fungoides | 001 | 3 | FDA | 9/6/2021 | $124,900 |
| | 2021 | 2021 | ELORAC, INC. | 100 FAIRWAY DR STE 134 | VERNON HILLS | IL | 60061-1859 | LAKE | USA | R01FD005396 | Naloxone Lotion for the Treatment of Pruritus in Mycosis Fungoides | 000 | 3 | FDA | 8/26/2021 | $173,100 |
|
| Issue Date FY: 2020 ( Subtotal = $0 ) |
| | 2020 | 2019 | ELORAC, INC. | 100 FAIRWAY DR STE 134 | VERNON HILLS | IL | 60061-1859 | LAKE | USA | R01FD005396 | Naloxone Lotion for the Treatment of Pruritus in Mycosis Fungoides | 000 | 2 | FDA | 7/31/2020 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $499,622 ) |
| | 2019 | 2019 | ELORAC, INC. | 100 FAIRWAY DR STE 134 | VERNON HILLS | IL | 60061-1859 | LAKE | USA | R01FD005396 | Naloxone Lotion for the Treatment of Pruritus in Mycosis Fungoides | 000 | 2 | FDA | 8/20/2019 | $499,622 |
|
| Issue Date FY: 2018 ( Subtotal = $0 ) |
| | 2018 | 2016 | ELORAC, INC. | 100 FAIRWAY DR STE 134 | VERNON HILLS | IL | 60061-1859 | LAKE | USA | R01FD005396 | Naloxone Lotion for the Treatment of Pruritus in Mycosis Fungoides | 000 | 1 | FDA | 7/30/2018 | $0 |
|
| Issue Date FY: 2017 ( Subtotal = $0 ) |
| | 2017 | 2016 | ELORAC, INC. | 100 FAIRWAY DR STE 134 | VERNON HILLS | IL | 60061-1859 | LAKE | USA | R01FD005396 | Naloxone Lotion for the Treatment of Pruritus in Mycosis Fungoides | 000 | 1 | FDA | 8/17/2017 | $0 |
|
| Issue Date FY: 2016 ( Subtotal = $499,622 ) |
| | 2016 | 2016 | ELORAC, INC | 100 FAIRWAY DRIVE SUITE 134 | VERNON HILLS | IL | 60061-1859 | LAKE | USA | R01FD005396 | Naloxone Lotion for the Treatment of Pruritus in Mycosis Fungoides | 000 | 1 | FDA | 9/5/2016 | $499,622 |
|
|
